Bahrain Approves Fondaio for Obesity
The National Authority for Regulation of Health Professions and Services in Bahrain has announced the approval of the medication "Vondaio" (Orforglyberon) for the treatment of type 2 diabetes. The drug is an oral medication belonging to the GLP-1 receptor class and is used to improve blood sugar control in patients suffering from this disease.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)